SYNLOGIC, INC. Increase (Decrease) in Deferred Charges
SYNLOGIC, INC. (SYBX) reported Increase (Decrease) in Deferred Charges of $0 for the 12-month period ending 2016-12-31, per its 10-K filed 2017-03-15.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDeferredCharges · last filed 2017-03-15
- SYNLOGIC, INC. increase (decrease) in deferred charges for the quarter ending 2015-03-31 was -$92.00K.
- SYNLOGIC, INC. increase (decrease) in deferred charges for the quarter ending 2014-12-31 was $65.00K.
- SYNLOGIC, INC. increase (decrease) in deferred charges for fiscal 2016 was $0.00.
- SYNLOGIC, INC. increase (decrease) in deferred charges for fiscal 2015 was $0.00.
- SYNLOGIC, INC. increase (decrease) in deferred charges for fiscal 2014 was -$105.00K, a 153.30% decline from fiscal 2013.
- SYNLOGIC, INC. increase (decrease) in deferred charges for fiscal 2013 was $197.00K.
| Period end | Increase (Decrease) in Deferred Charges 3 month | Increase (Decrease) in Deferred Charges 6 month | Increase (Decrease) in Deferred Charges 9 month | Increase (Decrease) in Deferred Charges 12 month |
|---|---|---|---|---|
| 2016-12-31 | $0.00 10-K · filed 2017-03-15 | |||
| 2015-12-31 | $0.00 10-K · filed 2017-03-15 | |||
| 2015-03-31 | -$92.00K 10-Q · filed 2016-05-12 | -$27.00K derived: sum of 2 quarters · filed 2017-03-15 | ||
| 2014-12-31 | $65.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-15 | -$105.00K 10-K · filed 2017-03-15 | ||
| 2014-09-30 | -$170.00K 10-Q · filed 2015-11-13 | |||
| 2013-12-31 | $197.00K 10-K · filed 2016-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |